Chemical Formula: C17H22N4O2

Chemical Formula C17H22N4O2

Found 15 metabolite its formula value is C17H22N4O2

Resiquimod

1-[2-(ethoxymethyl)-4-imino-1H,4H,5H-imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol

C17H22N4O2 (314.1742672)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent

   
   
   

Granisetron metabolite 4

Granisetron metabolite 4

C17H22N4O2 (314.1742672)


   

Moxiraprine

Moxiraprine

C17H22N4O2 (314.1742672)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   
   

5-METHYL-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE

5-METHYL-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE

C17H22N4O2 (314.1742672)


   

2-(Aminomethyl)phenol

2-(Aminomethyl)phenol

C17H22N4O2 (314.1742672)


   
   

Ralmitaront

Ralmitaront

C17H22N4O2 (314.1742672)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ralmitaront (RO6889450) is an orally active agonist of trace amine-associated receptor 1 (TAAR1) with a EC50 value of 110.4 nM. Ralmitaront has antipsychotic, cognitively improvement, and antidepressant activity in rodents. Ralmitaront can be used as a neurosuppressant in the study of neuro-related diseases, such as schizophrenia (SCZ), schizoaffective disorder[1][2][3][4].

   

N-[2-(dimethylamino)ethyl]-2-[3-(4-methylphenyl)-6-oxo-1-pyridazinyl]acetamide

N-[2-(dimethylamino)ethyl]-2-[3-(4-methylphenyl)-6-oxo-1-pyridazinyl]acetamide

C17H22N4O2 (314.1742672)


   

(5R,8R)-8-methyl-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

(5R,8R)-8-methyl-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one

C17H22N4O2 (314.1742672)


   

(4R,7R)-4-methyl-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

(4R,7R)-4-methyl-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one

C17H22N4O2 (314.1742672)


   

Resiquimod

Resiquimod

C17H22N4O2 (314.1742672)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent